Safety and efficacy of vildagliptin-metformin to glimepiride-metformin in type 2 diabetes mellitus patients - A comparative study
Journal Title: Medpulse International Journal of Pharmacology - Year 2019, Vol 10, Issue 2
Abstract
Background:Metformin and Vildagliptin have independent glucose-lowering properties and may increase GLP-1 levels by working through complementary mechanisms. The combination of metformin and glimepiride is a well-established therapy for type 2 DM.Aim: To compare the efficacy and safety of vildagliptin-metformin and glimepiride-metformin treatment in type 2 diabetic patients.Material and Methods:Patients was randomly assigned in (1:1) ratio after randomization to either of two groups (35 in each group), one group prescribed glimepiride(1mg) +metformin (500mg) twice daily half an hour before meals and other group vildagliptin(50mg)+ metformin(500mg) twice daily half an hour before meals. HbA1c, FBS, PPBS was repeated at the end of 3rd month.Results:The mean HbA1c levels at baseline (0 weeks) were 8.80 ±0.62and 8.99 ±0.37 in Group A and Group B respectively. Similarly, at 12 weeks mean HbA1c levels were 6.47±0.44 and 6.42±0.42 in Group A and Group B respectively. The change in percentage of HbA1c at 12 weeks was -26.06% and -27.86% in Group A and Group B respectively but no statistical significance different was found. (P=0.26). The HbA1c levels < 7 were achieved among 29 (41.43%) subjects in Group A as compared to 28 (40%) subjects in Group B.The difference between HbA1c levels among study groups was not statistically significant. (P=0.75).Conclusion:The efficacy and tolerability of vildagliptin, was similar, with no significant differences, when used to treat type 2 diabetic patients with inadequate blood glucose control by dual combination of metformin and glimepiride.
Authors and Affiliations
P KalaiSelvi, D Nishanthini
Keywords
Related Articles
- EP ID EP615747
- DOI 10.26611/10101022
- Views 125
- Downloads 0
Safety profile of atorvastatin in post myocardial infarction and post stroke patients
Background: The side effects of high dose atorvastatin treatment in post myocardial infarction and post stroke patients have not been studied in detail. The present work aim to study whether the toxicity profile of atorv...
Comparative effect of glimepride and metformin as a monotherapy on oxidative stress in T2DM patients
Aims and Objective: To compare antioxidant effect of glimepride and metformin alone in T2DM patients Material and Methods: T2DM patients having duration of less than 5 years were randomly selected and grouped in to two g...
Patterns of prescription in a psychiatry outpatient department in a tertiary teaching hospital
Background: There is constantly increasing prevalence of psychiatric morbidity in Jammu and Kashmir State. Study of prescription pattern helps us to monitor, evaluate and if necessary suggest modifications in prescribing...
Evaluation of knowledge, attitude and practice of adverse drug reaction reporting among registrars and consultants in a tertiary care hospital
Background: Spontaneous reporting is considered the main mechanism in the pharmacovigilance system by which the adverse drug reactions are identified after the drug is released onto the market. However, pharmacovigilance...
Comparison of effects of metformin with combination of glimepride and metformin in type 2 diabetes patients
Background: The use of a fixed-dose combination pill of sulfonylurea and metformin has recently increased. Using a fixed-dose combination pill can improve patient compliance. Aim: To compare the effects of tformin with c...